PROGENICS PHARMACEUTICALS, INC.

APYLITY

Radiopharmaceutical imaging and detection agents for detection, diagnosing and monitoring cancer; pharmaceutical preparations for the detection, diagnosis, prevention, treatment and monitoring of cancer;Providing medical testing services and information in the field of cancer diagnosis, treatment and prevention; Web-based medical testing for identification, quantification, diagnostic or treatment purposes in the field of cancer; providing medical information in the field of cancer identification, diagnosis, treatment and prevention; medical imaging services;Scientific research and development in the nature of research, development and preparation of pharmaceutical drugs and imaging agents for medical use; Providing temporary use of non-downloadable medical imaging software for the identification, quantification, diagnosis, prevention, treatment and monitoring of cancer;

AZEDRA

The mark consists of the stylized wording AZEDRA beneath a design of a triangle without a base forming a stylized letter A; the triangle design is formed by multiple smaller triangle designs.;Radiopharmaceutical compositions, namely, imaging and detection agents and therapeutic radiopharmaceutical preparations for treating neuro-endocrine cancers;Color is not claimed as a feature of the mark.;